The move marks the start-up of a new medical base in Taicang Port, focused on diagnostic reagents for early cancer detection. Keisai Biotech (Taicang) Co., Ltd., and Suzhou Hai Miao Biotechnology Co., Ltd. have joined the center.
China Bio news release, October 10, 2016